Sales/Maturities of Investments

$0.00

TTM · Period ending: Jun 30, 2026 · USD

MYGN Sales/Maturities of Investments

Latest reported$0.00period endingJun 30, 2026

MYGN TTM Sales/Maturities of Investments ($9.80M → $0.00)

TTM Sales/Maturities of Investments

High-resolution chart · PNG

MYGN sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2026	0
Mar 31, 2026	0
Dec 31, 2025	0
Sep 30, 2025	0
Jun 30, 2025	5,000,000
Mar 31, 2025	7,500,000
Dec 31, 2024	9,000,000
Sep 30, 2024	10,500,000
Jun 30, 2024	20,500,000
Mar 31, 2024	48,600,000
Dec 31, 2023	105,200,000
Sep 30, 2023	144,300,000
Jun 30, 2023	171,700,000
Mar 31, 2023	169,200,000
Dec 31, 2022	128,200,000
Sep 30, 2022	111,900,000
Jun 30, 2022	81,300,000
Mar 31, 2022	62,900,000
Dec 31, 2021	61,100,000
Sep 30, 2021	-15,300,000
Jun 30, 2021	-8,500,000
Mar 31, 2021	-5,500,000
Dec 31, 2020	0
Sep 30, 2020	70,200,000
Jun 30, 2020	69,000,000
Mar 31, 2020	83,700,000
Dec 31, 2019	82,600,000
Sep 30, 2019	80,300,000
Jun 30, 2019	79,200,000
Mar 31, 2019	64,000,000
Dec 31, 2018	64,600,000
Sep 30, 2018	76,100,000
Jun 30, 2018	77,700,000
Mar 31, 2018	83,400,000
Dec 31, 2017	99,700,000
Sep 30, 2017	92,600,000
Jun 30, 2017	163,400,000
Mar 31, 2017	174,000,000
Dec 31, 2016	152,700,000
Sep 30, 2016	172,000,000
Jun 30, 2016	115,100,000
Mar 31, 2016	111,398,000
Dec 31, 2015	156,398,000
Sep 30, 2015	129,798,000
Jun 30, 2015	165,598,000
Mar 31, 2015	181,870,000
Dec 31, 2014	348,403,000
Sep 30, 2014	391,689,000
Jun 30, 2014	380,935,000
Mar 31, 2014	425,030,000
Dec 31, 2013	290,362,000
Sep 30, 2013	317,047,000
Jun 30, 2013	384,560,000
Mar 31, 2013	390,626,000
Dec 31, 2012	387,640,000
Sep 30, 2012	442,937,000
Jun 30, 2012	385,236,000
Mar 31, 2012	399,784,000
Dec 31, 2011	463,631,000
Sep 30, 2011	456,579,000
Jun 30, 2011	456,072,000
Mar 31, 2011	153,183,000
Dec 31, 2010	98,408,000
Sep 30, 2010	60,254,000
Jun 30, 2010	52,160,000
Mar 31, 2010	297,380,000
Dec 31, 2009	213,881,000
Sep 30, 2009	145,282,000
Jun 30, 2009	111,849,000
Mar 31, 2009	81,433,000
Dec 31, 2008	119,918,000
Sep 30, 2008	144,951,000
Jun 30, 2008	174,420,000
Mar 31, 2008	208,200,000
Dec 31, 2007	211,138,000
Sep 30, 2007	182,262,000
Jun 30, 2007	162,480,000
Mar 31, 2007	154,519,000
Dec 31, 2006	131,883,000
Sep 30, 2006	128,463,000
Jun 30, 2006	100,470,000
Mar 31, 2006	94,615,000
Dec 31, 2005	61,909,000
Sep 30, 2005	62,900,000
Jun 30, 2005	70,956,000
Mar 31, 2005	46,128,000
Dec 31, 2004	58,710,000
Sep 30, 2004	57,145,000
Jun 30, 2004	58,640,000
Mar 31, 2004	59,920,000
Dec 31, 2003	53,901,000
Sep 30, 2003	58,257,000
Jun 30, 2003	50,707,000
Mar 31, 2003	131,372,489
Dec 31, 2002	136,509,555
Sep 30, 2002	123,923,371
Jun 30, 2002	137,181,371
Mar 31, 2002	42,405,882
Dec 31, 2001	29,872,816
Sep 30, 2001	21,577,000